Evidence-Based. Clearly Delivered.
Evidence-Based. Clearly Delivered.
In June 2017 the Iowa Supreme Court, in a 6-1 ruling (Plowman v. Fort Madison Community Hospital, No. 15–0974), recognized a personal injury claim for ‘wrongful birth’ for the first time. In March 2017, Texas as the twelfth state joined Arizona, Idaho, Indiana, Michigan, Minnesota, Missouri, North Carolina, North Dakota, Pennsylvania, South Dakota, and Utah to outlaw wrongful birth suits. Only 12 states have laws not allowing wrongful birth claims. The remaining states recognize the claim by statute or case law.
A wrongful birth claim arises when parents of a child born with a detectable birth defect allege that they would have avoided conception or terminated the pregnancy but for the physician’s negligent failure to inform them of the likelihood of the birth defect. The advances in the detectability of birth defects and genetic conditions coupled with the wide acceptance of prenatal testing support the acceptance of wrongful birth claims. In addition, a woman’s right to terminate a pregnancy also played a role.
In the Iowa case, the parents allege the defendants failed to accurately interpret, monitor, respond to, and communicate the fetal abnormalities. Ultrasound findings consisted of an abnormally small head and a sub-optimal view of brain anatomy at 22 weeks. Follow-up was recommended, but the parents were not informed of the ultrasound results. The parents stated that if they had been informed of the abnormalities, they would have terminated the pregnancy.
If successful on their claim in the trial court, then the issue of damages must be determined. Damages fall into two categories: economic and non-economic. Economic damages are medical costs, higher costs of raising and supporting a child with a disability, and loss of parental wages for not being to work while caring for the disabled child. Non-economic damages consist of compensation for emotional distress or mental anguish. Some states have placed limits on whether non-economic damages are compensable and how much compensation can be awarded.
SUPREME COURT OF IOWA No. 15–0974
Accuracy of diagnosis and counseling of fetal brain anomalies prior to 24 weeks of gestational age
The contents of the Site, such as text, graphics, images, information obtained from The ObG Project’s licensors, and other material contained on the Site (“Content”) are for informational purposes only. The Content is not intended to be a substitute for professional legal or medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of information you have read on the Site!
If you think you may have a medical emergency, call your doctor or 911 immediately. The ObG Project does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Site. Reliance on any information provided by The ObG Project, The ObG Project employees, others appearing on the Site at the invitation of The ObG Project, or other visitors to the Site is solely at your own risk.
The Site may contain health- or medical-related materials that are sexually explicit. If you find these materials offensive, you may not want to use our Site.
Children’s Privacy
We are committed to protecting the privacy of children. You should be aware that this Site is not intended or designed to attract children under the age of 13. We do not collect personally identifiable information from any child we reasonably believe is under the age of 13.
Please log in to ObGFirst to access this page
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
